• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟呼吸道衬液用于体外溶解研究。

Simulation of respiratory tract lining fluid for in vitro dissolution study.

机构信息

School of Pharmacy, University of Otago, Dunedin, New Zealand.

Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, Glebe, Australia.

出版信息

Expert Opin Drug Deliv. 2021 Aug;18(8):1091-1100. doi: 10.1080/17425247.2021.1882991. Epub 2021 Feb 5.

DOI:10.1080/17425247.2021.1882991
PMID:33504235
Abstract

: Drug particles inhaled via the respiratory system must first dissolve in the respiratory tract lining fluid (RTLF) that lies on the surfaces of airways and alveoli, so that they are absorbed and have therapeutic action. Artificial simulated RTLFs are often used for dissolution studies to determine the solubility and dissolution of inhaled drug particles. Such studies can be used to predict bioavailability minimizing the requirement for studies. Numerous studies have been conducted to develop bio-relevant simulated RTLFs; however, to date, there is no singular simulated RTLF that closely resembles human RTLF.: This review focuses on the composition of natural and simulated RTLFs and their use in dissolution studies.: There is variation in the composition and thickness of RTLF along the respiratory tract. Identification of the actual concentration of components of endogenous RTLF present in different areas of the respiratory tract helps in the development of region-specific simulated RTLFs. It is recommended that region-specific simulated RTLFs can be prepared by varying concentration of major RTLF components like mucus/gel simulants, lipids/surfactants, peptides/proteins, and inorganic/organic salts.

摘要

: 通过呼吸系统吸入的药物颗粒必须首先溶解在位于气道和肺泡表面的呼吸道衬里液(RTLF)中,以便被吸收并发挥治疗作用。人工模拟的 RTLF 常用于溶解研究,以确定吸入药物颗粒的溶解度和溶解。这些研究可用于预测生物利用度,从而减少研究需求。已经进行了许多研究来开发与生物相关的模拟 RTLF;然而,迄今为止,还没有一种单一的模拟 RTLF 非常接近人体 RTLF。: 本文综述了天然和模拟 RTLF 的组成及其在溶解研究中的应用。: RTLF 沿呼吸道的组成和厚度存在差异。确定呼吸道不同区域存在的内源性 RTLF 成分的实际浓度有助于开发特定区域的模拟 RTLF。建议通过改变主要 RTLF 成分(如粘液/凝胶模拟物、脂质/表面活性剂、肽/蛋白质和无机/有机盐)的浓度来制备特定区域的模拟 RTLF。

相似文献

1
Simulation of respiratory tract lining fluid for in vitro dissolution study.模拟呼吸道衬液用于体外溶解研究。
Expert Opin Drug Deliv. 2021 Aug;18(8):1091-1100. doi: 10.1080/17425247.2021.1882991. Epub 2021 Feb 5.
2
Oxidants, antioxidants, and respiratory tract lining fluids.氧化剂、抗氧化剂与呼吸道衬液
Environ Health Perspect. 1994 Dec;102 Suppl 10(Suppl 10):185-91. doi: 10.1289/ehp.94102s10185.
3
Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid.免疫调节蛋白在人呼吸道衬液中纳米颗粒生物分子冠层中的富集。
Nanomedicine. 2016 May;12(4):1033-1043. doi: 10.1016/j.nano.2015.12.369. Epub 2016 Jan 6.
4
Oxidative damage to extracellular fluids by ozone and possible protective effects of thiols.臭氧对细胞外液的氧化损伤及硫醇的可能保护作用。
Arch Biochem Biophys. 1995 Aug 1;321(1):43-50. doi: 10.1006/abbi.1995.1366.
5
Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.利用 PBPK 模型评估 Dissolv It 在口服吸入药物产品中的性能,Dissolv It 是一种生物相关的溶解检测方法。
Mol Pharm. 2019 Mar 4;16(3):1245-1254. doi: 10.1021/acs.molpharmaceut.8b01200. Epub 2019 Feb 15.
6
Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C.通过补充维生素C增加呼吸道内衬液中的抗坏血酸浓度。
Inhal Toxicol. 2009 Feb;21(3):250-8. doi: 10.1080/08958370802474736.
7
Antioxidant consumption and repletion kinetics in nasal lavage fluid following exposure of healthy human volunteers to ozone.健康人类志愿者暴露于臭氧后鼻腔灌洗液中的抗氧化剂消耗及补充动力学
Eur Respir J. 1999 Jun;13(6):1429-38. doi: 10.1183/09031936.99.13614399.
8
Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans.哮喘患者与健康人肺部颗粒沉积所获得的冠状蛋白质组的差异。
Nanomedicine. 2017 Nov;13(8):2517-2521. doi: 10.1016/j.nano.2017.06.008. Epub 2017 Jun 22.
9
Comparison of exhaled endogenous particles from smokers and non-smokers using multivariate analysis.使用多元分析比较吸烟者和非吸烟者呼出的内源性颗粒。
Respiration. 2013;86(2):135-42. doi: 10.1159/000350941. Epub 2013 Jun 28.
10
Release of beryllium into artificial airway epithelial lining fluid.铍释放到人工气道上皮衬液中。
Arch Environ Occup Health. 2012;67(4):219-28. doi: 10.1080/19338244.2011.619218.

引用本文的文献

1
Understanding the role of biomolecular coronas in human exposure to nanomaterials.了解生物分子冠层在人类接触纳米材料中的作用。
Environ Sci Nano. 2024 Sep 9;11(11):4421-4448. doi: 10.1039/d4en00488d. eCollection 2024 Nov 7.
2
Treatment of Idiopathic Pulmonary Fibrosis by Inhaled Silybin Dry Powder Prepared via the Nanosuspension Spray Drying Technology.纳米混悬液喷雾干燥技术制备的水飞蓟宾吸入干粉治疗特发性肺纤维化
ACS Pharmacol Transl Sci. 2023 May 18;6(6):878-891. doi: 10.1021/acsptsci.3c00033. eCollection 2023 Jun 9.
3
Dissolution and Absorption of Inhaled Drug Particles in the Lungs.
吸入药物颗粒在肺部的溶解与吸收
Pharmaceutics. 2022 Nov 30;14(12):2667. doi: 10.3390/pharmaceutics14122667.
4
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System.iBCS:1. 吸入型生物药剂学分类系统的原理和框架。
Mol Pharm. 2022 Jul 4;19(7):2032-2039. doi: 10.1021/acs.molpharmaceut.2c00113. Epub 2022 May 16.